Physiol Rev WPI Leader in Biosensing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Physiol. Rev. 86: 805-847, 2006; doi:10.1152/physrev.00014.2005
0031-9333/06 $18.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dufresne, M.
Right arrow Articles by Fourmy, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dufresne, M.
Right arrow Articles by Fourmy, D.

Cholecystokinin and Gastrin Receptors

Marlène Dufresne, Catherine Seva and Daniel Fourmy

Institut National de la Santé et de la Recherche Médicale U. 531, Institut Louis Bugnard, Centre Hospitalier Universitaire Rangueil, Toulouse, France

Cholecystokinin and gastrin receptors (CCK1R and CCK2R) are G protein-coupled receptors that have been the subject of intensive research in the last 10 years with corresponding advances in the understanding of their functioning and physiology. In this review, we first describe general properties of the receptors, such as the different signaling pathways used to exert short- and long-term effects and the structural data that explain their binding properties, activation, and regulation. We then focus on peripheral cholecystokinin receptors by describing their tissue distribution and physiological actions. Finally, pathophysiological peripheral actions of cholecystokinin receptors and their relevance in clinical disorders are reviewed.




This article has been cited by other articles:


Home page
 EndocrinologyHome page
T. Janssen, E. Meelkop, M. Lindemans, K. Verstraelen, S. J. Husson, L. Temmerman, R. J. Nachman, and L. Schoofs
Discovery of a Cholecystokinin-Gastrin-Like Signaling System in Nematodes
Endocrinology, June 1, 2008; 149(6): 2826 - 2839.
[Abstract] [Full Text] [PDF]

Home page
 Exp PhysiolHome page
H. L. Ashurst, A. Varro, and R. Dimaline
Regulation of mammalian gastrin/CCK receptor (CCK2R) expression in vitro and in vivo
Exp Physiol, February 1, 2008; 93(2): 223 - 236.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. Marco, M. Foucaud, I. Langer, C. Escrieut, I. G. Tikhonova, and D. Fourmy
Mechanism of Activation of a G Protein-coupled Receptor, the Human Cholecystokinin-2 Receptor
J. Biol. Chem., September 28, 2007; 282(39): 28779 - 28790.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W. Rengifo-Cam, S. Umar, S. Sarkar, and P. Singh
Antiapoptotic Effects of Progastrin on Pancreatic Cancer Cells Are Mediated by Sustained Activation of Nuclear Factor-{kappa}B
Cancer Res., August 1, 2007; 67(15): 7266 - 7274.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
P. Clerc, M. G. Coll Constans, H. Lulka, S. Broussaud, C. Guigne, S. Leung-Theung-Long, C. Perrin, C. Knauf, C. Carpene, L. Penicaud, et al.
Involvement of Cholecystokinin 2 Receptor in Food Intake Regulation: Hyperphagia and Increased Fat Deposition in Cholecystokinin 2 Receptor-Deficient Mice
Endocrinology, March 1, 2007; 148(3): 1039 - 1049.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
S. M. Clee and A. D. Attie
The Genetic Landscape of Type 2 Diabetes in Mice
Endocr. Rev., February 1, 2007; 28(1): 48 - 83.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.